A checklist for statistical assessment of medical papers (the CHAMP statement): explanation and elaboration MA Mansournia, GS Collins, RO Nielsen, M Nazemipour, NP Jewell, ... British journal of sports medicine 55 (18), 1009-1017, 2021 | 142 | 2021 |
Reflection on modern methods: demystifying robust standard errors for epidemiologists MA Mansournia, M Nazemipour, AI Naimi, GS Collins, MJ Campbell International Journal of Epidemiology 50 (1), 346-351, 2021 | 142 | 2021 |
Seroprevalence of SARS-CoV-2 in guilan province, Iran, April 2020 M Shakiba, M Nazemipour, A Salari, F Mehrabian, SSH Nazari, ... Emerging infectious diseases 27 (2), 636, 2021 | 74 | 2021 |
Update on SARS-CoV-2 seroprevalence: regional and worldwide A Rostami, M Sepidarkish, A Fazlzadeh, AH Mokdad, A Sattarnezhad, ... Clinical Microbiology and Infection 27 (12), 1762-1771, 2021 | 60 | 2021 |
To adjust or not to adjust: the role of different covariates in cardiovascular observational studies M Etminan, JM Brophy, G Collins, M Nazemipour, MA Mansournia American Heart Journal 237, 62-67, 2021 | 48 | 2021 |
Bland-Altman methods for comparing methods of measurement and response to criticisms MA Mansournia, R Waters, M Nazemipour, M Bland, DG Altman Global Epidemiology 3, 100045, 2021 | 40 | 2021 |
Prevalence of asymptomatic COVID-19 infection using a seroepidemiological survey M Shakiba, M Nazemipour, A Heidarzadeh, MA Mansournia Epidemiology & Infection 148, e300, 2020 | 36 | 2020 |
Causal diagrams for immortal time bias MA Mansournia, M Nazemipour, M Etminan International journal of epidemiology 50 (5), 1405-1409, 2021 | 34 | 2021 |
Potential biases in studies of acid-suppressing drugs and COVID-19 infection M Etminan, M Nazemipour, MA Mansournia Gastroenterology 160 (5), 1443-1446, 2021 | 34 | 2021 |
P-value, compatibility, and S-value MA Mansournia, M Nazemipour, M Etminan Global epidemiology 4, 100085, 2022 | 31 | 2022 |
Risk factors of developing critical conditions in Iranian patients with COVID-19 A Arman, M Tajik, M Nazemipour, Z Ahmadinejad, SK Shahrestanaki, ... Global epidemiology 3, 100046, 2021 | 20 | 2021 |
A practical guide to handling competing events in etiologic time-to-event studies MA Mansournia, M Nazemipour, M Etminan Global Epidemiology 4, 100080, 2022 | 19 | 2022 |
The causal effect and impact of reproductive factors on breast cancer using super learner and targeted maximum likelihood estimation: a case-control study in Fars Province, Iran A Almasi-Hashiani, S Nedjat, R Ghiasvand, S Safiri, M Nazemipour, ... BMC Public Health 21 (1), 1219, 2021 | 19 | 2021 |
Population attributable fraction in textbooks: time to revise A Khosravi, M Nazemipour, T Shinozaki, MA Mansournia Global Epidemiology 3, 100062, 2021 | 18 | 2021 |
Effect of smoking on breast cancer by adjusting for smoking misclassification bias and confounders using a probabilistic bias analysis method R Pakzad, S Nedjat, M Yaseri, H Salehiniya, N Mansournia, ... Clinical epidemiology, 557-568, 2020 | 17 | 2020 |
Estimating the marginal causal effect and potential impact of waterpipe smoking on risk of multiple sclerosis using the targeted maximum likelihood estimation method: a large … I Abdollahpour, S Nedjat, A Almasi-Hashiani, M Nazemipour, ... American journal of epidemiology 190 (7), 1332-1340, 2021 | 15 | 2021 |
Interaction contrasts and collider bias MA Mansournia, M Nazemipour, M Etminan American Journal of Epidemiology 191 (10), 1813-1819, 2022 | 14 | 2022 |
Time-fixed vs time-varying causal diagrams for immortal time bias MA Mansournia, M Nazemipour, M Etminan International journal of epidemiology 51 (3), 1030-1031, 2022 | 12 | 2022 |
The effects of smoking on metabolic syndrome and its components using causal methods in the Iranian population F Khodamoradi, M Nazemipour, N Mansournia, K Yazdani, D Khalili, ... International Journal of Preventive Medicine 12 (1), 118, 2021 | 11 | 2021 |
Challenges for management of the COVID-19 epidemic in Iran A Doosti-Irani, E Mostafavi, M Nazemipour, MA Mansournia, ... Global epidemiology 2, 100035, 2020 | 11 | 2020 |